Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer. (Q54493330)

30 May 2018

title

Reduced expression of Raf kinase inhibitor protein correlates with poor prognosis in pancreatic cancer. (English)

1 reference

30 May 2018

author name string

Shi-peng Song

1

1 reference

30 May 2018

Sheng-bin Zhang

2

1 reference

30 May 2018

Zhe-hai Li

3

1 reference

30 May 2018

Yong-sheng Zhou

4

1 reference

30 May 2018

Bing Li

5

1 reference

30 May 2018

Zhan-wei Bian

6

1 reference

30 May 2018

Qian-de Liao

7

1 reference

30 May 2018

Yang-de Zhang

8

1 reference

30 May 2018

publication date

24 July 2012

1 reference

30 May 2018

Clinical and Translational Oncology

published in

1 reference

30 May 2018

volume

14

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

848-852

1 reference

30 May 2018

Loss of E-cadherin expression and outcome among patients with resectable pancreatic adenocarcinomas.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

RKIP inhibits NF-kappaB in cancer cells by regulating upstream signaling components of the IkappaB kinase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Effects of raf kinase inhibitor protein expression on metastasis and progression of human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

BRAF and RKIP are significantly decreased in cutaneous squamous cell carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Reduced expression of Raf-1 kinase inhibitory protein is a significant prognostic marker in patients with gallbladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Raf kinase inhibitor protein: mechanism of loss of expression and association with genomic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Signaling crossroads: the function of Raf kinase inhibitory protein in cancer, the central nervous system and reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

Proteomic profiling for cancer progression: Differential display analysis for the expression of intracellular proteins between regressive and progressive cancer cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0870-7

TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer

21 January 2018

1 reference

12 December 2020

Clinical and molecular determinants of survival in pancreatic cancer patients treated with second-line chemotherapy: results of an Italian/Swiss multicenter survey.

1 reference

12 December 2020

Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression

1 reference

12 December 2020

Metastasis suppressors in human benign prostate, intraepithelial neoplasia, and invasive cancer: their prospects as therapeutic agents

1 reference

12 December 2020

10.1007/S12094-012-0870-7

Identifiers

DOI

1 reference

30 May 2018

1 reference

30 May 2018